‘Press Releases’ Category

Paxil Victims React to FDA’s Announcement re Suicide Risk in Children — Baum, Hedlund, Aristei, Guilford & Schiavo; Attorneys Representing Thousands of Paxil Victims Respond

Paxil Victims React to FDA's Announcement re Suicide Risk in Children -- Baum, Hedlund, Aristei, Guilford & Schiavo; Attorneys Representing Th...


Paxil Victims React to FDA’s Announcement re Suicide Risk in Children — Baum, Hedlund, Aristei, Guilford & Schiavo; Attorneys Representing Thousands of Paxil Victims Respond

(PRWEB) June 22, 2003

–“Finally, after faced with public pressure from the recent action by U.K regulators, the FDA has agreed to review reports of increased risk of suicide caused by Paxil,” stated attorney Karen Barth, of the national law firm Baum, Hedlund, Aristei, Guilford & Schiavo. She is responding to today’s statement by the Food and Drug Administration (FDA) recommending that the antidepressant Paxil not be used in children or adolescents for the treatment of depression.

Link to FDA’s Advisory: http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01230.html

The data revealed that Paxil can triple the risk of suicidal behavior in minors. “Of course, because Paxil can cause serious withdrawal symptoms, including severe dizziness, nausea, ‘electric zap’ sensations, and ’emotional lability’ (defined by Paxil maker GlaxoSmithKline (GSK) as ‘crying, mood fluctuations, self-harm, suicidal thoughts and attempted suicide’), the FDA has put an advisory in all capital letters and in a box at the top of its statement that it is ‘essential’ that Paxil not be stopped suddenly. (It took the FDA a decade before it forced GSK to change its warning about Paxil withdrawal.) In other words, kids are damned if they do and damned if they don’t,” stated Attorney Barth.

The Los Angeles-based law firm of Baum, Hedlund, Aristei, Guilford & Schiavo represents victims of both the suicide side effects caused by the SSRIs (the class of antidepressant drugs known as the selective serotonin reuptake inhibitors, Paxil, Zoloft and Prozac) and the withdrawal side effects caused by Paxil and Zoloft. Baum Hedlund represents thousands of Paxil victims and has been litigating failure-to-warn cases against the drug companies who manufacture these antidepressants for 12 years.

Attorney Karen Barth added: “I hope I am wrong in my skepticism about the FDA and that it does not white-wash the suicide risk as it has done in the past. But the FDA’s recent actions cause me concern. The FDA this past year joined forces with Pfizer, the manufacturer of Zoloft, by submitting an amicus (‘friend of the court’) brief in one of our Zoloft suicide cases, stating that it would not allow Pfizer to place a suicide warning in the label for Zoloft even if Pfizer sought to include one because, to do so, according to FDA attorneys, would misbrand the drug.”

Baum Hedlund later learned that the FDA’s intervention in the case was the result of a telephone call between the FDA’s newly appointed Chief Counsel, Daniel Troy, and Pfizer’s national counsel. Alarmingly, Baum Hedlund also learned that Mr. Troy worked for Pfizer during the pendency of the case.

“The FDA is violating its own mandate to act in the interests of the American consuming public by taking sides with the pharmaceutical companies it is supposed to police,” Barth stated.

After hearing the news of the FDA’s intervention in these cases, numerous law professors and attorneys have contacted the Baum Hedlund firm about the impropriety of the FDA’s involvement in private litigation in favor of drug companies. The current regulatory administration, including not only Daniel Troy, but also Alexander Azar, the General Counsel of the Department of Health & Human Services, has not been phased; but instead, has continued its public campaign by giving speeches at industry seminars and recruiting pharmaceutical defense attorneys to support its position.

The FDA also intervened to prevent a United States District Court judge in California from forcing Paxil’s manufacturer, GlaxoSmithKline, to stop airing television commercials that proclaimed Paxil to be “non-habit forming.”

Link: http://www.baumhedlundlaw.com/media/ssri/paxil/Injunction/pr_inj3.htm

Barth further stated: “The FDA is already sanitizing its action with numerous statements that Paxil is okay for adults, whereas the U.K. regulators said they will ‘examine urgently’ these data with regard to the use of SSRIs in adults. I fear the FDA, under its current administration, lacks the ability to do a truly objective analysis. In one of our suicide cases, the FDA’s position is based upon inconclusive and biased reviews done over ten years ago. Does that mean on a child’s 18th birthday this risk suddenly disappears? For example, one of our client’s children killed himself at age 19. Perhaps we need to remind the FDA of the 8 million dollar verdict a Wyoming jury awarded in 2000 against GSK in a case where a man taking Paxil killed his wife, his daughter, his granddaughter and then committed suicide.

“The manufacturers of the SSRIs, including GSK, have continuously and adamantly denied even the possibility of a causal connection between the SSRIs and suicide, and, instead, have blamed the victim and the ‘disease.’ This is notwithstanding clear evidence very early on in the clinical trials of these drugs that they can cause these problems. We have documents obtained through discovery in our litigation showing that there was an awareness of the problem as far back as the late 1970s, long before the first SSRI (Prozac) was approved for marketing in this country. In fact, the German equivalent to the FDA (the ‘BGA’) initially refused to license Prozac for distribution in that country due to the disproportionate number of suicides in the clinical trials. Germany eventually allowed the drug on the market, however, only with a stronger suicide warning. The reality is that all of the SSRIs, Paxil, Zoloft and Prozac, share the same side effect profile regarding suicide and the safety of these drugs needs to be re-examined, objectively.”

According to a study released on June 1, 2003, in the Journal of the American Academy of Child and Adolescent Psychiatry: “SSRIs have become the most rapidly increasing psychotropic used to treat children and adolescents in the United States.”

Link to background information and UK ban: http://www.baumhedlundlaw.com/media/ssri/paxil/UKchildren.htm

Baum Hedlund has been litigating SSRI cases around the country for over a decade. They were on the “Plaintiffs’ Steering Committee” in the first SSRI-suicide litigation involving Prozac (the first SSRI approved by the FDA for marketing in the U.S.) in the early 1990s. The firm has represented families of suicide victims, including the widow of 1960s rock star, Del Shannon, and the family of comedian Phil Hartman and his wife, Brynn. The firm represents clients in suicide and injury cases against the makers of Paxil and Zoloft. Baum Hedlund attorney Karen Barth was on the trial team in one of the only SSRI suicide cases to go to trial. Additionally, Baum Hedlund filed the first Paxil class action lawsuit related to withdrawal.

VocusВ©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Related Zoloft Press Releases

CME Outfitters Announces Live CE Audioconference Series: “Depression with Atypical Features Part I: Recognition, Diagnosis, and Management” Premieres Tuesday, June 20


CME Outfitters Announces Live CE Audioconference Series: “Depression with Atypical Features Part I: Recognition, Diagnosis, and Management” Premieres Tuesday, June 20

Rockville, MD (PRWEB) May 30, 2006

CME Outfitters, LLC, nationally accredited provider of multidisciplinary medical education programming and related healthcare communications services, is pleased to announce an upcoming live and interactive evidence-based psychCME TALK audioconference series titled “Depression with Atypical Features Part I: Recognition, Diagnosis, and Management.”

Offered as a series of 15 live and interactive audioconferences premiering Tuesday, June 20, 2006, from 2:15–3:15 p.m. ET, the series will focus on providing evidence-based educational information and clinical context regarding the efficacy of medications used in the treatment of depression with atypical features. This CE activity will also be available as an archived telephone audioconference shortly after the audioconference premiere, and available as an archived webcast, podcast, and multimedia CD-ROM in July.

There is no fee for participation in this activity, or to obtain a CE certificate; however, registration is required. Three forms of registration are accepted:

Online: Visit the activity details page at http://www.cmeoutfitters.com/cmea.asp?ID=210

Phone: Call 877.CME.PROS (877.263.7767)

Fax: Visit the activity details page at http://www.cmeoutfitters.com/cmea.asp?ID=210, print and complete the activity details form, and fax to 240.243.1033

Statement of Need:

Depression with atypical features is characterized by mood reactivity in conjunction with any two of the following – hypersomnia, leaden paralysis, hyperphagia, and interpersonal rejection sensitivity. Some data show that patients with depression with atypical features experience greater functional impairment than their non-atypical counterparts, as well as exhibiting more interpersonal sensitivity, more chronic dysphoria, and more bipolar II disorder. There is some uncertainty regarding how to best characterize patients with depression with atypical features because patients with bipolar disorder, anxious depression, and personality disorder all share similar presentations. Over the years, treatment of depression with atypical features has ranged from monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, selective serotonin reuptake inhibitors, bupropion, venlafaxine, and cognitive behavioral therapy. Emerging data demonstrate that newer delivery systems may provide a statistically significant and improved antidepressant benefit. In this first of a two-part evidence-based and interactive CME Outfitters/psychCME TALK series, the experts will help clinicians to recognize, diagnose, and manage depression with atypical features. Part two will incorporate the information from this session and focus on clinical case studies of patients with this condition. It will be introduced later this year.


Charles B. Nemeroff, MD, PhD

Reunette W. Harris Professor and Chairman

Department of Psychiatry and Behavioral Sciences

Emory University School of Medicine

Atlanta, GA

Alan F. Schatzberg, MD

Kenneth T. Norris, Jr., Professor and Chairman

Department of Psychiatry and Behavioral Sciences

Stanford University School of Medicine

Stanford, CA

Learning Objectives:

At the end of this CE activity, participants should be able to:

Differentiate the unique symptomatology of depression with atypical features from other depressive disorders.

Compare and contrast the receptor profiles of various treatment options for patients with depression with atypical features.

Evaluate the strength of evidence for novel treatments and delivery systems in patients with depression with atypical features.

Target Audience:

Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals with an interest in mental health.

Commercial Support:

CME Outfitters, LLC, gratefully acknowledges an educational grant from Bristol-Myers Squibb Company in support of this CE activity.

Credit Information:

CME Credit (Physicians):

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)в„ў. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):

This Educational Activity is presented by CME Outfitters, LLC, which has been approved as a provider of continuing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. It has been assigned code 5UYSJZ-PRV-0496. 1.2 contact hours (Pharmacology)

CEP Credit (Psychologists):

CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)

NASW Credit (Social Workers):

This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.

CCMC Credit (Certified Case Managers):

This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).

CPE Credit (Pharmacists):

CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)

Universal Program Number: 376-999-06-012-L01 (live interactive session) 376-999-06-012-H01 (recorded activities)

To receive credit, participants must review all activity materials in their entirety, score 70% or above on a post-test, and fully complete and return both the credit request form and activity evaluation. A certificate or statement of credit will be mailed within 4-6 weeks to all who successfully complete these requirements.

About CME Outfitters:

CME Outfitters is a full service healthcare communications agency providing continuing education content development, production, marketing, accreditation, and project management services to the healthcare industry. Among its many collaborative ventures, CME Outfitters has played a primary role in the production, certification, marketing, and logistical support for the popular psychCME series of educational activities. For more information on CME Outfitters, including a complete calendar of its free award-winning educational activities, please visit http://www.cmeoutfitters.com, or call 877.CME.PROS (877.263.7767).

To view all of CME Outfitters’ recent press releases, visit http://www.cmeoutfitters.com and click on “CME Outfitters in the News” or visit http://www.prweb.com and search for “CME Outfitters.”

CME Outfitters publishes a weekly e-newsletter, which is a convenient way to stay informed of all CME Outfitters news and information. To subscribe, visit http://www.cmeoutfitters.com and click on “Register for Updates.”

Contact: Jessica Primanzon

CME Outfitters, LLC

240.243.1308 direct

240.243.1033 fax

# # #


VocusВ©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Medical Dictionary Search Engines http://www.medical-dictionary-search-engines.com announced that the new drug and medication price comparison services available to the public.


Medical Dictionary Search Engines http://www.medical-dictionary-search-engines.com announced that the new drug and medication price comparison services available to the public.

(PRWEB) May 27, 2004

Medical Dictionary Search Engines http://www.medical-dictionary-search-engines.com is one of the best health research sites available for public to search for drug, medicine, and any health questions with price comparison on some commonly used drugs.

The grouped sections in AIDS, Stroke, Diabetes and Cancer help public to locate helpful reference from research group around the world.

We also provide price comparison on popular drugs available online, for an example Viagra, Propecia, Xenical, Phentermine, Adipex, Meridia, Bontril, Didrex, Ionamin, Tenuate, Acyclovir, Valtrex, Renova, Retin-A, Vaniqa, Celebrex, Ultram, Vioxx, Ortho Tri-Cyclen, Zyban, Allegra, Claritin, and Flonase.

Our new services provide up-to-date price comparison on the following drugs and medications,

Bontril Uses, http://bontril.medical-dictionary-search-engines.com/ This medication is used as an appetite suppressant. It is used in conjunction with an overall diet plan to reduce weight.

Didrex Uses, http://didrex.medical-dictionary-search-engines.com/ This medicine is an appetite suppressant used along with diet, exercise, and behavior therapy for the short-term management of obesity.

Ionamin Uses, http://ionamin.medical-dictionary-search-engines.com/ This medication is used as an appetite suppressant. It is used in conjunction with an overall diet plan to reduce weight.

Tenuate Uses, http://tenuate.medical-dictionary-search-engines.com/ This medicine is an appetite suppressant used along with diet, exercise, and behavior therapy for the short-term management of obesity.

Acyclovir Uses, http://acyclovir.medical-dictionary-search-engines.com/ Acyclovir is an antiviral used to treat shingles, chickenpox, or genital herpes. It may also be used to treat other conditions.

Valtrex Uses, http://valtrex.medical-dictionary-search-engines.com/ This medication is an antiviral agent used in the treatment of herpes zoster (shingles), genital herpes and is also being used for herpes simplex (cold sores).

Renova Uses, http://renova.medical-dictionary-search-engines.com/ This medication is used to improve the appearance of the skin by reducing fine lines and wrinkles, reducing roughness and improving coloration. This can also be used to treat acne.

Retin-A Uses, http://retin-a.medical-dictionary-search-engines.com/ This medication is used in the treatment of acne. It reduces the formation of pimples and promotes quick healing of pimples that do develop.

Vaniqa Uses, http://vaniqa.medical-dictionary-search-engines.com/ This medicine is an enzyme inhibitor used topically to slow the growth of unwanted facial hair in women. It does not remove hair.

Celebrex Uses, http://celebrex.medical-dictionary-search-engines.com/ This medicine is a nonsteroidal anti-inflammatory drug (NSAID) known as a COX-2 inhibitor used to relieve the symptoms of osteoarthritis and rheumatoid arthritis in adults. It may also be used to treat other conditions as determined by your doctor.

Vioxx Uses, http://vioxx.medical-dictionary-search-engines.com/ This medicine is a nonsteroidal anti-inflammatory drug (NSAID) known as a COX-2 inhibitor used to relieve the symptoms of osteoarthritis and to treat pain and menstrual discomfort.

About the website above:

Is built for new generation of eCommerce which committed to simplifying the life of millions internet users in a new way online shopping. The site and the supporting staff are dedicated to make eCommerce and online shopping fun, reliable, and easy. The site is easy to use and help merchants to minimize setup and maintenance, while maximizing return on investment. For more information please feel free to contact us.


Data and information provided by the above website(s), contents, materials, goods, and or services are for informational purposes only. The creator, webmaster, and the related staff of the website(s) shall not be liable for any errors in the content. For detail please visit the disclaimer section of the website(s).

VocusВ©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Tips for Natural Ways of Lowering High Cholesterol


New York, NY (PRWEB) September 14, 2010

Patients Medical, a leading integrative medical center in New York City, reminds adults to get their serum cholesterol tested and offers tips on how to lower high cholesterol safely and naturally, in observance of National Cholesterol Education Month (September).

Serum cholesterol is the level of lipids (fat) in your blood. Traditionally, high low-density lipoproteins (LDLs) and low high-density lipoproteins (HDLs) are a red flag for cardiovascular disease and heart attacks. “Most conventional doctors would prescribe a statin such as Lipitor or Crestor to bring down high LDL’s, but some of these prescriptions may have side effects that severely affect the patient’s quality of life, including nausea, kidney failure, insomnia, erectile dysfunction, as well as nerve and liver damage,” explains Dr. Rashmi Gulati, Medical Director at Patients Medical.

“In cases that are not acute, diet and lifestyle modification are very effective in balancing cholesterol. Simply by eliminating junk food, increasing the amount of whole, nutritious foods consumed, including appropriate exercise and stress management techniques, many peoples’ cholesterol levels balance effectively without the use of any prescribed substance,” says Dr. Gulati.

Plant sterols are another approach to treating high LDL’s that has received media attention lately. “These phytosterols are naturally-derived substances, popping up in fortified foods and as supplements that have shown to be gentler than statins while helping to lower the LDL’s by blocking absorption of cholesterol in the intestines. They are being used as a safer alternative to statins with great success in tandem with diet and lifestyle modifications,” adds Dr. Gulati.

Patients Medical’s team of physicians seeks to educate their patients and the general public on cholesterol, heart health and overall wellness. The next complimentary webinar, “Is Your Cholesterol Medicine Killing You?” will be held on Thursday, September 16th at 6:30pm Eastern. Dr. Gulati will discuss holistic ways of treating high cholesterol and will address harmful effects of statins and benefits of more natural substances like plant sterols, and will also answer questions from participants.

About Patients Medical

Patients Medical (http://www.patientsmedical.com ) is a unique integrative medicine center in Manhattan that combines the best of traditional and holistic medicine with modern technology to provide comprehensive care. Established in 1974, the center employs a multi-disciplinary staff including Board Certified Internists, licensed practitioners and nutritionists. The practice specializes in diagnosing the root cause of an ailment, then healing the whole person with personalized protocols that draw upon ancient healing techniques alongside Western Medical perspectives.


Related Lipitor Press Releases

Results From A Recent FLAVORx Survey Reveal The Majority Of People Do Not Take Medicine Properly — This Could Prove Very Dangerous Now At The Height Of Cold and Flu Season


Bethesda, MD (PRWEB) February 16, 2006

Results were just released from a quiz that was given to the public by FLAVORx, Inc on December 14th, 2005. The results reveal that in regards to issues of compliance and taking medicine properly, very few people are aware of how to take their medication responsibly so they get better and don’t infect others. Surprisingly, most people take medication to the extent that they feel it is sufficient to their health by their own standards, which, in almost all cases, is completely inconsistent with what physicians, pharmacists, healthcare practitioners and drug manufacturers recommend. With experts predicting the arrival of cold and flu’s peak season next week, FLAVORx has released its findings to promote health education and awareness to prevent persistent symptoms, the spread of infection and drug resistance.

Both the flu and cold are frequent and expensive diseases. The common cold may strike some people as many as 12 times per year, which averages approximately 15 million days lost from work in the U.S. The flu is highly contagious and typically affects about 20-50% of the US population annually.

Of the approximately 230 people that were polled, most were extremely surprised to see that they had not fared well in the multi question quiz. The first question addressed the actions most commonly taken when people receive a prescription from their doctor. Approximately 74% of respondents believed that in lieu of getting the prescription filled immediately, they would instead wait a few days to see if their body could naturally fight off or clear the illness or infection. Unfortunately, this is not the correct behavior. If your physician prescribes a medication for you, it is because your body requires it.

If you are uncertain of whether to seek professional guidance during cold and flu season, follow these guidelines for when it is necessary to contact your doctor: a fever greater than 101Вє F for more than 3 days, or an oral temperature of 103Вє F. For fever, aches and pain; pain relievers and fever reducers like TylenolВ® (Acetaminophen) or AdvilВ® or MotrinВ® (Ibuprofen) are usually helpful. If your child has to take the liquid Acetaminophen or Ibuprofen the taste might make them less compliant so a safe flavoring such as FLAVORx can be used to ensure compliance.

Most importantly, while your body may be able to fight the infection, other bodies may not—meaning that the longer you wait to treat an illness or infection, the longer you are able to transmit the virus or bacteria to somebody else. This leads to continual infection of others and exponential spread of the illness.

The second biggest misconception among respondents is that once you physically feel better, you can stop taking a medication. This behavior is a major contributor to more resistant and virulent strains of illness over time. The optimal treatment time for a medication has been determined by pharmaceutical researchers. While you may no longer exhibit symptoms, the bacteria or virus may still be present in the body. Taking a medication for an incomplete regimen (often due to taste in children) allows the virus to become resistant to a certain medication. If you have not taken the whole regimen and the virus comes back the medicine will not be as effective or effective at all. Due to taste this is an overriding concern in babies and children that just can not tolerate the taste of a liquid medication thus reducing compliance and making recovery much slower. Kids can pick a safe, reliable flavoring to change the taste of their medication so that they can swallow it and thus be compliant.

Lastly, respondents also seem to have been misled by the safety of taking un-prescribed medications. Even if you feel that you have had an illness before, or have taken a certain medication before, you should never take a medication that hasn’t been specifically prescribed for you. Dosages and drug regimens differ for each individual patient. Contact your doctor of pharmacist before trying to self-diagnose or self-prescribe.

The ramifications of non-compliance, or not taking your medication properly, are much more serious than most people believe. According to the American Hospital Association, 125,000 deaths were attributed to non-compliance in 2004.

The U.S. Food and Drug Administration (FDA) considers 3 active ingredients safe and effective for relieving certain symptoms of the cold or flu. These include nasal decongestants (like SudafedВ®, and AfrinВ®) antitussives/cough suppressants (like Robitussin DMВ® and DelsymВ®) and expectorants (like RobitussinВ® and VicksВ®). Many people find these medications to taste less than good and have a very hard time swallowing them. Sometimes this bad taste is the main reason for the non compliance that too often keeps our population sick.

When medication is necessary, FLAVORx suggests using a specifically developed and scientifically tested flavoring to improve the typically unpalatable taste of liquid medications. FLAVORx offers 42 flavors that can be applied to both over-the-counter and prescription medications and is available at most pharmacies nationwide. To date, over 50 million prescriptions have been successfully flavored without any report of complication, changes in efficacy or incidence of allergy.

For more information, please visit www.flavorx.com or contact Teresa Chen at 800.884.5771, extension 234.

# # #